SCHEMBL3393077

SCHEMBL3393077

NC(=O)c1cc(-c2ccsc2)cc2c(C3CCNCC3)n[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 6/20 0.47
CHUK O15111 2/20 0.47
RPS6KB1 P23443 2/20 0.47
PDPK1 O15530 1/20 0.47
CDC7 O00311 1/20 0.40
CHEK1 O14757 3/20 0.39
KCNH2 Q12809 1/20 0.39
CDK2 P24941 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
BTK Q06187 2/20 0.38
CSF1R P07333 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
AXL P30530 1/20 0.35
CHEK2 O96017 1/20 0.35
PARP1 P09874 2/20 0.34
KDM5A P29375 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3396662 0.99 IKBKB (0.46) IKBKBCHUKRPS6KB1PDPK1CDC7
SCHEMBL27698208 0.86 RPS6KB1 (0.40) IKBKBCHUKRPS6KB1PDPK1CHEK1
SCHEMBL3391461 0.85 IKBKB (0.64) IKBKBCHUKRPS6KB1PDPK1BTK
Hydrochloric Acid SCHEMBL3395054 0.84 IKBKB (0.63) IKBKBCHUKRPS6KB1PDPK1BTK
SCHEMBL3392932 0.83 IKBKB (0.53) IKBKBCHUKRPS6KB1PDPK1CHEK1
SCHEMBL3391210 0.82 IKBKB (0.46) IKBKBCHUKCDC7CHEK1CDK2
Hydrochloric Acid SCHEMBL3395928 0.82 IKBKB (0.45) IKBKBCHUKCDC7CHEK1CDK2
SCHEMBL3396344 0.81 IKBKB (0.49) IKBKBCHUKCDC7CDK2BTK
SCHEMBL3391862 0.81 GPR119 (0.47) PARP1KDM5A
SCHEMBL3393266 0.80 MKNK1 (0.53) IKBKBCHUKCDC7CHEK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501780-B2 Indazole carboxamides and their use GLAXOSMITHKLINE LLC (US) 2013-08-06 US disclosed
US-8501780-B2 Indazole carboxamides and their use GLAXOSMITHKLINE LLC (US) 2013-08-06 US disclosed
US-8501780-B2 Indazole carboxamides and their use GLAXOSMITHKLINE LLC (US) 2013-08-06 US disclosed
EP-1758578-B1 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE GLAXOSMITHKLINE LLC (US) 2010-12-29 EP disclosed
EP-1758578-B1 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE GLAXOSMITHKLINE LLC (US) 2010-12-29 EP disclosed
EP-1758578-A4 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE SMITHKLINE BEECHAM CORP (US) 2009-05-27 EP disclosed
US-20070281933-A1 Novel Indazole Carboxamides And Their Use SMITHKLINE BEECHAM CORPORATION (US) 2007-12-06 US disclosed
US-20070281933-A1 Novel Indazole Carboxamides And Their Use SMITHKLINE BEECHAM CORPORATION (US) 2007-12-06 US disclosed
US-20070281933-A1 Novel Indazole Carboxamides And Their Use SMITHKLINE BEECHAM CORPORATION (US) 2007-12-06 US disclosed
CN-101005836-A Novel indazole carboxamides and their use SMITHKLINE BEECHAM CORP (US) 2007-07-25 CN disclosed
EP-1758578-A2 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE Smithkline Beecham Corporation (US) 2007-03-07 EP disclosed
WO-2006002434-A2 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2006-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281933-A1 Novel Indazole Carboxamides And Their Use IKBKG, IRAK2, NFKBIA IKBKB 8/4885CHUK 9/4885RPS6KB1 543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.